Volume 33(2025) > Number 3 | The economic burden of COVID-19 in a region with stringent response measures: A case study of Taiwan | Elise Chia-Hui Tan, Fei-Yuan Hsiao, Ming-Chin Yang | 326-338 |
Volume 33(2025) > Number 3 | Development and validation of an analytical method for determination of bongkrekic acid in biofluids for toxin monitoring | Ying-Tzu Shieh, Te-I Weng, Ju-Yu Chen, I-Ting Wang, Kevin Shu-Leung Lai, Chia-Mo Lin, Chu-Yun Teng, Guan-Yuan Chen | 339-347 |
Volume 33(2025) > Number 2 | Aspergillosis: A comprehensive review of pathogenesis, drug resistance, and emerging therapeutics | Amanpreet Singh, Jeewanjot Singh, Sandeep Kumar | 75-96 |
Volume 33(2025) > Number 2 | Regulatory framework and challenges for live biotherapeutic products in Taiwan | Shirley Pan, Jia-Chuan Hsu, Kuo-Teng Hung, Ching-Jung Ho | 97-105 |
Volume 33(2025) > Number 2 | Jiao San Xian granule containing prebiotic alleviate functional dyspepsia by regulating intestinal flora and the secretion of inflammatory response | Huimin Pei, Mengyuan Zhao, Hongyue Wang, Xindi Zhang, Caihong Shi, Xiangrong Zhang | 106-118 |
Volume 33(2025) > Number 2 | Integrating network analysis and experimental validation to reveal the ferroptosis-associated mechanism of velvet antler in the treatment of chronic atrophic gastritis | Quan Liao, Zhenzhen Guo, Chenchun Ding, Renjie Zuo and Guoyan Liu | 119-131 |
Volume 33(2025) > Number 2 | In vitro metabolic profiling of methylenedioxy-substituted synthetic cathinones for enhanced detection in urine sample analysis | Ya-Ling Yeh, Chin-Lin Hsieh, Yi-Jia Huang, Yu-Hsiang Chang and Sheng-Meng Wang | 132-149 |
Volume 33(2025) > Number 2 | Ping-Chong-Jiang-Ni Formula effectively inhibits migration and invasion of endometriosis 12Z cell line via TRIP13 | Jiahua Peng, Shuzhen Liu, Yunxiang Xie, Min Xiao, Chichiu Wang, Ruining Liang | 150-162 |
Volume 33(2025) > Number 2 | Evaluating the cost-effectiveness of atezolizumab-bevacizumab in advanced hepatocellular carcinoma: Insights from Taiwan | Tsung-Wei Chang, Wei-Chiao Chang, Wan-Hsuan Chou, Wei-Pin Chang, Chun-Nan Kuo | 163-171 |
Volume 33(2025) > Number 2 | Yiqi Yangyin Tongluo prescription targets lncRNA VIM-AS1 to regulate FOXK2/mTOR to promote autophagy and inhibit renal tubular epithelial cell apoptosis | Rucui Yu, Ruiying Wu, Tingting Chen, Jingwei Xu | 172-178 |